Your browser doesn't support javascript.
loading
Increased SLAMF7high monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.
Maekawa, Takaaki; Kato, Shoichiro; Kawamura, Toshikuni; Takada, Kohei; Sone, Takehiro; Ogata, Hiraku; Saito, Keita; Izumi, Takuya; Nagao, Shigeki; Takano, Kosuke; Okada, Yosuke; Tachi, Noriaki; Teramoto, Masahiro; Horiuchi, Toshikatsu; Hikota-Saga, Reina; Endo-Umeda, Kaori; Uno, Shigeyuki; Osawa, Yukiko; Kobayashi, Ayako; Kobayashi, Shinichi; Sato, Ken; Hashimoto, Michihiro; Suzu, Shinya; Usuki, Kensuke; Morishita, Soji; Araki, Marito; Makishima, Makoto; Komatsu, Norio; Kimura, Fumihiko.
Afiliação
  • Maekawa T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Kato S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Kawamura T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Takada K; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Sone T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Ogata H; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Saito K; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Izumi T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Nagao S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Takano K; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Okada Y; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Tachi N; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Teramoto M; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Horiuchi T; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Hikota-Saga R; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Endo-Umeda K; Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan.
  • Uno S; Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan.
  • Osawa Y; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Kobayashi A; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Kobayashi S; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Sato K; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
  • Hashimoto M; International Research Center for Medical Sciences, and.
  • Suzu S; Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan; and.
  • Morishita S; Department of Transfusion Medicine and Stem Cell Regulation and.
  • Araki M; Department of Transfusion Medicine and Stem Cell Regulation and.
  • Makishima M; Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan.
  • Komatsu N; Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Kimura F; Division of Hematology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
Blood ; 134(10): 814-825, 2019 09 05.
Article em En | MEDLINE | ID: mdl-31270105

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos / Janus Quinase 2 / Mielofibrose Primária / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos / Janus Quinase 2 / Mielofibrose Primária / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2019 Tipo de documento: Article